The broad offering at DLA Piper spans expertise across regulatory, transactions, product liability and patent litigation. Birmingham-based practice head Richard Taylor assists clients ranging from multinationals to public bodies on issues such as IP licensing and procurement. Also in Birmingham, Ryan Harrison excels in advising on cross-border commercial agreements. Mark Dewar’s expertise extends to advising on risk across supply chains. In Leeds, IP and commercial law specialist Kate Black is further recommended.
Legal 500 Editorial commentary
Key clients
- Dechra Pharmaceuticals
- Cancer Research UK
- Medica Group plc
- Argenx
- QMD (Q Medical Devices)
- Anthony Nolan Trust
- International Health Partners
- Curasight
- Pfizer
- Medtronic
Work highlights
Advising Pfizer in the UK, highlights this year including advising Pfizer on its contractual arrangements with the EU for supply of the Covid vaccine.
Advising FTSE100 global veterinary pharmaceuticals business Dechra Pharmaceuticals on the GBP4.46bn take private backed by EQT. .
Advised on over 30 pro bono matters opened for Cancer Research UK, continuing our close pro bono partnership with CRUK. We are particularly proud of our work this year supporting CRUK’s Bowelbabe Fund and the legacy of the late Dame Deborah James.
Lawyers
Practice head
Richard Taylor
Other key lawyers
Ryan Harrison; Mark Dewar; Tom Heylen; Teresa Hitchcock; Kate Black